| Bekheit Salamoon, MD | |
|
8401 Market St, Boardman, OH 44512-6725 | |
| (330) 729-4298 | |
| (330) 729-1591 |
| Full Name | Bekheit Salamoon |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Location | 8401 Market St, Boardman, Ohio |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447879457 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 35.148907 (Ohio) | Secondary |
| 208M00000X | Hospitalist | 35.148907 (Ohio) | Primary |
| Entity Name | Trinity West |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043234677 PECOS PAC ID: 5496648875 Enrollment ID: O20040209000132 |
News Archive
Advanced Cell Diagnostics Inc. (ACD), a technology and market leader in the field of molecular pathology and developer of cell and tissue-based RNA analysis tools, has announced the launch of its new website, www.acdbio.com.
An experimental drug improves the ability of heart muscle cells damaged by heart failure to pump blood, according to the results of a study led by Icahn School of Medicine at Mount Sinai researchers and published online today in Nature Communications.
Conducted by two university professors and a director for the Food and Drug Administration, the review examines the consequences of switching to hydrofluoroalkane, which is replacing chlorofluorocarbon, or CFC, as a key ingredient in albuterol inhalers designed to relieve asthma. The FDA has ruled that U.S. sales of CFC albuterol inhalers be prohibited after 2008.
Adding once-daily lixisenatide to basal insulin treatment is effective at improving glycemic control in Asian patients with Type 2 diabetes, show study findings.
› Verified 3 days ago
| Entity Name | Mercy Health Physicians Youngstown Specialty Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649892225 PECOS PAC ID: 3476950296 Enrollment ID: O20210921003835 |
News Archive
Advanced Cell Diagnostics Inc. (ACD), a technology and market leader in the field of molecular pathology and developer of cell and tissue-based RNA analysis tools, has announced the launch of its new website, www.acdbio.com.
An experimental drug improves the ability of heart muscle cells damaged by heart failure to pump blood, according to the results of a study led by Icahn School of Medicine at Mount Sinai researchers and published online today in Nature Communications.
Conducted by two university professors and a director for the Food and Drug Administration, the review examines the consequences of switching to hydrofluoroalkane, which is replacing chlorofluorocarbon, or CFC, as a key ingredient in albuterol inhalers designed to relieve asthma. The FDA has ruled that U.S. sales of CFC albuterol inhalers be prohibited after 2008.
Adding once-daily lixisenatide to basal insulin treatment is effective at improving glycemic control in Asian patients with Type 2 diabetes, show study findings.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bekheit Salamoon, MD 8401 Market St, Boardman, OH 44512-6725 Ph: (330) 729-4298 | Bekheit Salamoon, MD 8401 Market St, Boardman, OH 44512-6725 Ph: (330) 729-4298 |
News Archive
Advanced Cell Diagnostics Inc. (ACD), a technology and market leader in the field of molecular pathology and developer of cell and tissue-based RNA analysis tools, has announced the launch of its new website, www.acdbio.com.
An experimental drug improves the ability of heart muscle cells damaged by heart failure to pump blood, according to the results of a study led by Icahn School of Medicine at Mount Sinai researchers and published online today in Nature Communications.
Conducted by two university professors and a director for the Food and Drug Administration, the review examines the consequences of switching to hydrofluoroalkane, which is replacing chlorofluorocarbon, or CFC, as a key ingredient in albuterol inhalers designed to relieve asthma. The FDA has ruled that U.S. sales of CFC albuterol inhalers be prohibited after 2008.
Adding once-daily lixisenatide to basal insulin treatment is effective at improving glycemic control in Asian patients with Type 2 diabetes, show study findings.
› Verified 3 days ago
Dr. Timothy Lockso, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 8401 Market St, Boardman, OH 44512 Phone: 330-729-4298 Fax: 330-729-1897 | |
Dr. Jayshree Rajesh Saraiya, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 8401 Market St, Boardman, OH 44512 Phone: 330-729-4298 Fax: 330-729-1897 | |
Timothy Aaron Hric, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 8401 Market St, Boardman, OH 44512 Phone: 330-729-4298 Fax: 330-729-1897 | |
Larry Maturani, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 8401 Market St, Boardman, OH 44512 Phone: 330-729-4298 Fax: 330-480-2926 | |
Lawrence A Shaffer, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 6505 Market St, Boardman, OH 44512 Phone: 330-746-8100 | |
Dr. Neha J Tilton, D.O Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 8401 Market St, Boardman, OH 44512 Phone: 330-729-4298 Fax: 330-729-1897 |